keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TPEQM-DMA, a NIR-II photosensitizer, selectively accumulates in cancerous mitochondria and demonstrates potent type-I phototherapeutic efficacy that inhibits the growth of cancer cells. This efficacy aids in overcoming the intrinsic limitations of photodynamic therapy (PDT) in treating hypoxic tumors [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | TPEQM-DMA, a NIR-II photosensitizer, selectively accumulates in cancerous mitochondria and demonstrates potent type-I phototherapeutic efficacy that inhibits the growth of cancer cells. This efficacy aids in overcoming the intrinsic limitations of photodynamic therapy (PDT) in treating hypoxic tumors [1]. |
Molecular Weight | N/A |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.